𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erythropoietin response in anaemic patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow

✍ Scribed by S. Ariad; A. P. MacPhail; W. R. Bezwoda; D. Clifford; G. Penfold

Book ID
114791526
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
410 KB
Volume
49
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VAD chemotherapy—toxicity and efficacy—i
VAD chemotherapy—toxicity and efficacy—in patients with multiple myeloma and other lymphoid malignancies
✍ Dr H. Anderson; J. H. Scarffe; M. Lambert; D. B. Smith; C. C. Chan; G. Chadwick; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Thirty-three patients with multiple myeloma (11 untreated, 15 refractory and seven relapsed patients) have received vincristine and adriamycin infusion therapy with oral dexamethasone (VAD). The median number of course received was five. In addition 16 patients with lymphoid malignancy have received

Allogeneic bone marrow transplantation i
Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the ebmt registry
✍ Professor G. Gahrton; S. Tura; M. Flesch; A. Gratwohl; P. Gravett; A. Lindeberg; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

Twenty-four patients with multiple myeloma received an allogeneic bone-marrow graft from HLAcompatible sibling donors (n = 23), or a twin donor (n = 1). Eighteen patients are alive, 1-36 months post bone-marrow transplantation (median 14 months). Ten of these patients had no signs ofmultiple myeloma